Literature DB >> 22617248

The relationship between volume or surgeon specialty and outcome in the surgical treatment of lung cancer: a systematic review and meta-analysis.

Erik M von Meyenfeldt1, Gea A Gooiker, Willem van Gijn, Piet N Post, Cornelis J H van de Velde, Rob A E M Tollenaar, Houke M Klomp, Michel W J M Wouters.   

Abstract

BACKGROUND: Whether improvement of quality of surgical cancer care can be achieved by centralizing care in high-volume specialized centers is a subject of ongoing debate. We have conducted a meta-analysis of the literature on the effect of procedural volume or surgeon specialty on outcome of lung resections for cancer.
METHODS: A systematic search of articles published between January 1, 1990 and January 20, 2011 on the effects of surgeon specialty and hospital or surgeon volume of lung resections on mortality and survival was conducted. After strict inclusion, meta-analysis assuming a random-effects model was performed. Meta-regression was used to identify volume cutoff values. Heterogeneity and the risk of publication bias were evaluated.
RESULTS: Nineteen relevant studies were found. Studies were heterogeneous, especially in defining volume categories. The pooled estimated effect size was significant in favor of high-volume hospitals regarding postoperative mortality (odds ratio [OR] 0.71; confidence interval 0.62-0.81), but not for survival (OR 0.93; confidence interval 0.84-1.03). Surgeon volume showed no significant effect on outcome. General surgeons had significantly higher mortality risks than general thoracic (OR 0.78; 0.70-0.88) or cardiothoracic surgeons (OR 0.82; 0.69-0.96). A minimal annual volume of resections for lung cancer could not be identified.
CONCLUSIONS: Hospital volume and surgeon specialty are important determinants of outcome in lung cancer resections, but evidence-based minimal-volume standards are lacking. Evaluation of individual institutions in a national audit program might help elucidate the influence of individual quality-of-care parameters, including hospital volume, on outcome.

Entities:  

Mesh:

Year:  2012        PMID: 22617248     DOI: 10.1097/JTO.0b013e318257cc45

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  26 in total

1.  Radical surgery for malignant pleural mesothelioma: have we identified the appropriate selection tools?

Authors:  Nico van Zandwijk; Glen Reid; Anthony Linton; Steven Kao
Journal:  Ann Cardiothorac Surg       Date:  2012-11

2.  Does surgeon experience affect outcomes in pathologic stage I lung cancer?

Authors:  Paul J Scheel; Traves D Crabtree; Jennifer M Bell; Christine Frederiksen; Stephen R Broderick; A Sasha Krupnick; Daniel Kreisel; G Alexander Patterson; Bryan F Meyers; Varun Puri
Journal:  J Thorac Cardiovasc Surg       Date:  2014-12-20       Impact factor: 5.209

3.  Impact of a learning curve model in kidney transplantation on functional outcome and surgical complications in a small volume centre: does size really matter?

Authors:  Guido Fechner; Ilja Seifert; Stefan Hauser; Stefan C Müller
Journal:  Int Urol Nephrol       Date:  2012-07-26       Impact factor: 2.370

4.  Readiness for Implementation of Lung Cancer Screening. A National Survey of Veterans Affairs Pulmonologists.

Authors:  Melissa H Tukey; Jack A Clark; Rendelle Bolton; Michael J Kelley; Christopher G Slatore; David H Au; Renda Soylemez Wiener
Journal:  Ann Am Thorac Soc       Date:  2016-10

Review 5.  Is It Time to Centralize Ovarian Cancer Care in the United States?

Authors:  Renee A Cowan; Roisin E O'Cearbhaill; Ginger J Gardner; Douglas A Levine; Kara Long Roche; Yukio Sonoda; Oliver Zivanovic; William P Tew; Evis Sala; Yulia Lakhman; Hebert A Vargas Alvarez; Debra M Sarasohn; Svetlana Mironov; Nadeem R Abu-Rustum; Dennis S Chi
Journal:  Ann Surg Oncol       Date:  2015-10-28       Impact factor: 5.344

Review 6.  Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.

Authors:  Nico van Zandwijk; Christopher Clarke; Douglas Henderson; A William Musk; Kwun Fong; Anna Nowak; Robert Loneragan; Brian McCaughan; Michael Boyer; Malcolm Feigen; David Currow; Penelope Schofield; Beth Ivimey Nick Pavlakis; Jocelyn McLean; Henry Marshall; Steven Leong; Victoria Keena; Andrew Penman
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

7.  Lung cancer: Stage III NSCLC - is it time to centralize care?

Authors:  William J Mackillop; Christopher M Booth
Journal:  Nat Rev Clin Oncol       Date:  2016-09-27       Impact factor: 66.675

8.  Impact of Surgeon Specialty on Perioperative Outcomes of Surgery for Benign Esophageal Diseases: A NSQIP Analysis.

Authors:  Zeyad Khoshhal; Joseph Canner; Eric Schneider; Miloslawa Stem; Elliott Haut; Francisco Schlottmann; Arianna Barbetta; Benedetto Mungo; Anne Lidor; Daniela Molena
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2017-06-08       Impact factor: 1.878

Review 9.  Lung cancer care: the impact of facilities and area measures.

Authors:  Christopher S Lathan
Journal:  Transl Lung Cancer Res       Date:  2015-08

10.  Predicting lung cancer prior to surgical resection in patients with lung nodules.

Authors:  Stephen A Deppen; Jeffrey D Blume; Melinda C Aldrich; Sarah A Fletcher; Pierre P Massion; Ronald C Walker; Heidi C Chen; Theodore Speroff; Catherine A Degesys; Rhonda Pinkerman; Eric S Lambright; Jonathan C Nesbitt; Joe B Putnam; Eric L Grogan
Journal:  J Thorac Oncol       Date:  2014-10       Impact factor: 15.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.